CARM Shares Outstanding History — Carisma Therapeutics Share Count Over Time

As of 8/5/2025 Carisma Therapeutics has 41.79 million CARM shares outstanding. Investors often track the CARM shares outstanding history to compare shareholder return trends against the change in share count over time.

This page shows CARM share count trends over time, with 8 historical shares outstanding datapoints presented, dating back to 8/9/2023.

Quick links: Shares Outstanding History Table  |  Shares Outstanding History Chart  |  About Carisma Therapeutics
CARM Shares Outstanding History



Below is a table of the CARM shares outstanding history going back to 8/9/2023:

Date CARM Shares Outstanding
8/9/202340.28M
11/6/202340.36M
3/15/202441.54M
5/7/202441.54M
8/6/202441.54M
11/5/202441.75M
3/26/202541.79M
8/5/202541.79M

Also see: CARM Market Cap History
CARM YTD Return
CARM Historical Shares Outstanding:
+1.86% CAGR
CARM Historical Shares Outstanding: +1.86% CAGR

Mouse over chart for data details
8/9/2023 ...8/5/2025
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing its proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. It is developing a pipeline of product candidates, with an initial focus on advancing multiple ex vivo autologous and in vivo CAR-M therapies for the treatment of solid tumors. Its first product candidate, CT-0508, is an ex vivo gene-modified autologous chimeric antigen receptor-monocyte (CAR-Monocyte) cellular therapy intended to treat solid tumors that overexpress human epidermal growth factor receptor 2 (HER2). We show 8 historical shares outstanding datapoints in our coverage of CARM's shares outstanding history.

Understanding the changing numbers of CARM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CARM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CARM by allowing them to research CARM shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CARM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance
Carisma Therapeutics (CARM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CASI Shares Outstanding History
CASM Shares Outstanding History
CATB Shares Outstanding History
CATS Shares Outstanding History
CBAY Shares Outstanding History
CBIO Shares Outstanding History
CBLI Shares Outstanding History
CBM Shares Outstanding History
CBMG Shares Outstanding History
CBPO Shares Outstanding History
More Healthcare companies »
 

CARM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.